| Title： | Guidelines for Exercise Prescription in Chronic Obstructive Pulmonary Disease |
| Edition： | Original |
| Classification： | Standard guideline |
| Field： | Others |
| Countries and regions： | China |
| Guidelines users： | This guideline is intended for clinical physicians, nurses, rehabilitation therapists, health managers, fitness trainers, exercise prescription specialists, COPD patients and their families, researchers, educators, and students in related fields, as well as public groups such as government healthcare policymakers and media professionals. |
| Evidence classification method： | Using the GRADE system, the quality of evidence is categorized into four levels: high, moderate, low, and very low. The strength of recommendations is indicated by the number of stars, with more stars signifying stronger recommendations. The secretariat and the evidence assessment group compile all evidence for each clinical question, presenting the types of studies and the quality of evidence, thereby creating detailed evidence summary tables. |
| Development unit： | Beijing Sport University、China Sport Science Society |
| Registration time: | 2024-05-22 |
| Registration number： | |
| Purpose of the guideline: | The guidelines for exercise prescription in chronic obstructive pulmonary disease (COPD) are intended to provide evidence-based support for healthcare professionals, sports science specialists, and researchers in China. These guidelines aim to enhance the application of exercise prescriptions for COPD in clinical practice, scientific research, and classroom teaching, thereby ensuring significant value in these areas. |
Latest registration
